Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.

D.E. Furst; F.C. Breedveld; J.R. Kalden; J.S. Smolen; G.-R. Burmester; J.W.J. Bijlsma; M. Dougados; P. Emery; E.C. Keystone; L. Klareskog; P.J. mease

Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.

Translated title of the contribution: Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.

D.E. Furst, F.C. Breedveld, J.R. Kalden, J.S. Smolen, G.-R. Burmester, J.W.J. Bijlsma, M. Dougados, P. Emery, E.C. Keystone, L. Klareskog, P.J. mease

Rheumatology & Clinical Immunology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.
Original language	Undefined/Unknown
Pages (from-to)	iv2-iv14
Number of pages	12
Journal	Annals of the Rheumatic Diseases
Volume	64
Issue number	4
Publication status	Published - 2005

Cite this

Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G.-R., Bijlsma, J. W. J., Dougados, M., Emery, P., Keystone, E. C., Klareskog, L., & mease, P. J. (2005). Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Annals of the Rheumatic Diseases, 64(4), iv2-iv14.

@article{bd4b579802014b7daec98f7cffe9e784,

title = "Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.",

author = "D.E. Furst and F.C. Breedveld and J.R. Kalden and J.S. Smolen and G.-R. Burmester and J.W.J. Bijlsma and M. Dougados and P. Emery and E.C. Keystone and L. Klareskog and P.J. mease",

year = "2005",

language = "Undefined/Unknown",

volume = "64",

pages = "iv2--iv14",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "4",

}

Furst, DE, Breedveld, FC, Kalden, JR, Smolen, JS, Burmester, G-R, Bijlsma, JWJ, Dougados, M, Emery, P, Keystone, EC, Klareskog, L & mease, PJ 2005, 'Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.', Annals of the Rheumatic Diseases, vol. 64, no. 4, pp. iv2-iv14.

Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. / Furst, D.E.; Breedveld, F.C.; Kalden, J.R. et al.
In: Annals of the Rheumatic Diseases, Vol. 64, No. 4, 2005, p. iv2-iv14.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.

AU - Furst, D.E.

AU - Breedveld, F.C.

AU - Kalden, J.R.

AU - Smolen, J.S.

AU - Burmester, G.-R.

AU - Bijlsma, J.W.J.

AU - Dougados, M.

AU - Emery, P.

AU - Keystone, E.C.

AU - Klareskog, L.

AU - mease, P.J.

PY - 2005

Y1 - 2005

M3 - Article

SN - 0003-4967

VL - 64

SP - iv2-iv14

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 4

ER -